SEA
RMD icon

Stegent Equity Advisors’s ResMed RMD Stock Holding History

Stegent Equity Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-835
Closed -$229K – 127
2025
Q3 		$229K Sell
835
-2,229
-73% -$609K 0.19% 106
2025
Q2 		$791K Sell
3,064
-169
-5% -$40.3K 0.7% 41
2025
Q1 		$724K Sell
3,233
-245
-7% -$57.2K 0.73% 42
2024
Q4 		$795K Buy
+3,478
New +$837K 0.81% 38

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Stegent Equity Advisors's RMD Position: Q4 2025 in Review

Stegent Equity Advisors sold out of ResMed (RMD) in Q4 2025, closing a stake of 835 shares — an estimated $229K sold.

Stegent Equity Advisors first reported a position in RMD in Q4 2024 and held it in 4 quarters. The position peaked at $795K in Q4 2024. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Stegent Equity Advisors reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Stegent Equity Advisors sold 835 ResMed shares in Q4 2025, an estimated $229K.
  • Stegent Equity Advisors first reported a position in ResMed in Q4 2024 and held it in 4 quarters.
  • Stegent Equity Advisors's ResMed position peaked at $795K in Q4 2024.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Stegent Equity Advisors's 13F filing for Q4 2025, filed 14 Jan 2026.